Azicip Azithromycin 250mg

Azithromycin 250mg Product Overview

Azithromycin 250mg is a macrolide antibiotic used for certain bacterial infections when prescribed by a qualified healthcare professional. The content should provide clear product information covering its composition, common uses, mechanism of action, dosage and administration, possible side effects, warnings and precautions, storage requirements and prescription considerations.

Azicip Azithromycin 250mg is a prescription macrolide antibiotic tablet containing Azithromycin as its active ingredient, manufactured by Cipla Ltd, one of the world’s most respected and globally recognized pharmaceutical companies. Azithromycin is a broad-spectrum antibiotic that effectively stops the growth and reproduction of a wide range of susceptible bacteria, allowing the body’s immune system to clear the infection and restore health.

What makes Azicip particularly valued in clinical practice is its long tissue half-life and excellent bioavailability, which allows it to accumulate in infected tissues and continue working effectively even after the last dose is taken. This unique pharmacological property enables shorter treatment courses compared to many older antibiotics while maintaining highly effective antibacterial concentration at the site of infection.

Azicip 250 Mg is available in a convenient 6-tablet strip format and is prescribed for a diverse range of bacterial conditions, making it one of the most versatile and patient-friendly antibiotics available in the market today.

Active Ingredient

Azithromycin is a second-generation macrolide antibiotic derived from erythromycin with enhanced antibacterial spectrum and improved pharmacokinetic properties. It demonstrates excellent activity against both gram-positive and gram-negative bacteria as well as atypical organisms including Chlamydia, Mycoplasma, and Legionella species.